相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NF-κB and cancer -: identifying targets and mechanisms
Willscott E. Naugler et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Akt shows variable sensitivity to an Hsp90 inhibitor depending on cell context
Maria A. Theodoraki et al.
EXPERIMENTAL CELL RESEARCH (2007)
Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo
Christian Moser et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
Sven A. Lang et al.
CLINICAL CANCER RESEARCH (2007)
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
Xiong-Zhi Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma
David Semela et al.
JOURNAL OF HEPATOLOGY (2007)
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
Sven A. Lang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice
Shin-ichiro Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells
Daniela Matei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma
Lanie K. Francis et al.
CLINICAL CANCER RESEARCH (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
Thuy L. Phung et al.
CANCER CELL (2006)
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues
Lata T. Gooljarsingh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer
D Ito et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Pericytes and vascular stability
D von Tell et al.
EXPERIMENTAL CELL RESEARCH (2006)
Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis
S Sanderson et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Role of HSP90, CDC37, and CRM1 as modulators of P16INK4A activity in rat liver carcinogenesis and human liver cancer
RM Pascale et al.
HEPATOLOGY (2005)
Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides
S Fichtner-Feigl et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
K Nakanishi et al.
CANCER (2005)
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer
CJ Bruns et al.
CLINICAL CANCER RESEARCH (2004)
Targeting multiple signal transduction pathways through inhibition of Hsp90
H Zhang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2004)
被撤回的出版物: The potential role of hypoxia inducible factor 1α in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma (Retracted article. See vol. 78, pg. 3399, 2018)
ZF Yang et al.
CANCER RESEARCH (2004)
mTOR and P70S6 kinase expression in primary liver neoplasms
F Sahin et al.
CLINICAL CANCER RESEARCH (2004)
The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins
LS Harrington et al.
JOURNAL OF CELL BIOLOGY (2004)
Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells
O Riesterer et al.
ONCOGENE (2004)
Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice
V Schmitz et al.
JOURNAL OF HEPATOLOGY (2004)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Heat shock protein 90 as a molecular target for cancer therapeutics
JS Isaacs et al.
CANCER CELL (2003)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
The IGF axis and hepatocarcinogenesis
JG Scharf et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
分享论文
